Position in NVS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$15,672
+$397 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,511
of 1,602 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hamrick Investment Counsel, llc holds $5,443,287 across 11 Drug Manufacturers - General names. NVS ranks #8 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
8,334 | $3,017,908 | |
| 2 | PFE |
Pfizer Inc
|
47,457 | $1,142,764 | |
| 3 | JNJ |
Johnson & Johnson
|
3,774 | $958,482 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,640 | $210,740 | |
| 5 | LLY |
ELI LILLY & Co
|
35 | $41,980 | |
| 6 | ABBV |
AbbVie Inc.
|
100 | $25,164 | |
| 7 | SNY |
Sanofi
|
450 | $19,197 | |
| 8 | NVS |
Novartis AG
This page
|
100 | $15,672 |
All Filings in NVS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,672 | 100 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $15,275 | 100 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $13,787 | 100 | Shares | Sole | 2026-04-01 | |
| No filing history on record for this holder in this stock. | ||||||